059-2 Wyo. Code R. §§ 2-3 - Definitions
(a) "Collaborative pharmacy practice" is that
practice of pharmacy whereby one or more pharmacists have jointly agreed, on a
voluntary basis, to work in conjunction with one or more practitioners in
collaboration to provide patient care services to achieve optimal medication
use and desired patient outcomes.
(b) "Collaborative practice agreement" is a
written and signed agreement between one or more pharmacists and one or more
practitioners that defines a collaborative practice.
(c) "Compounding" means the preparation,
mixing, assembling, altering, packaging, or labeling of a drug, drug-delivery
device, or device, unless performed in a Food and Drug Administration
(FDA)-registered outsourcing facility in conformance with Federal law, in
accordance with a licensed practitioner's prescription, medication order, or
initiative based on the practitioner/patient/pharmacist/compounder relationship
in the course of professional practice. Compounding includes the following:
(i) Preparation of drug dosage forms for both
human and animal patients;
(ii)
Preparation of drugs or devices in anticipation of prescription drug orders
based on routine, regularly observed prescribing patterns; and
(iii) Manipulation of commercial products for
patient-specific needs beyond FDA-approved labeling.
(iv) Compounding does not include mixing,
reconstituting, adding flavoring or other such acts that are performed in
accordance with directions contained in approved labeling provided by the
product's manufacturer and other manufacturer directions consistent with the
labeling.
(d) "Deliver"
or "delivery" means the actual, constructive or attempted transfer from one
person to another of a drug or device, whether or not there is an agency
relationship.
(e) "Dispense" or
"Dispensing" means the interpretation, evaluation, and implementation of a
prescription drug order, including the preparation, final verification, and
delivery of a drug or device to a patient or patient's agent in a suitable
container appropriately labeled for subsequent administration to, or use by, a
patient.
(f) "Fill date" means the
date that a new or refilled prescription was prepared, verified and labelled.
It may or may not be the date the medication was received by the
patient.
(g) "Labeling" means the
process of preparing and affixing a label to any drug container, exclusive of
the labeling by a manufacturer, packager or distributor.
(h) "Medication refill consolidation" means a
component of medication therapy management that recognizes the authority of the
pharmacist, at the patient's directions, to proactively adjust the medication
quantity or refill schedule and to manage a patient's maintenance medications
by coordinating the refill schedules, not to exceed the total quantity
prescribed, to improve patient outcomes.
(i) "Medication therapy management" (MTM) is
a distinct service or group of services that optimize therapeutic outcomes for
individual patients. MTM services are independent of, but can occur in
conjunction with, the provision of a medication or a medical device. MTM
encompasses a broad range of professional activities and responsibilities
within the licensed pharmacist's scope of practice.
(j) "Patient counseling" means the verbal
communication by the pharmacist of information, to the patient or caregiver, in
order to encourage proper use of drugs and devices. Patient counseling may be
supplemented with printed materials. For medications provided by delivery,
patient counseling may be provided in writing, and shall indicate the manner or
method that the patient may use to contact a pharmacist for counseling or to
answer questions.
(k) "Pharmacist
care" are those patient care activities provided by a pharmacist, with or
without the dispensing of drugs or devices, that are intended to achieve
positive clinical outcomes and to optimize the patient's health-related quality
of life.
(l) "Pharmacist-in-Charge"
("PIC") means a licensed pharmacist has the authority to direct the pharmacy's
operations and staff.
(m)
"Prescription drug order" means a lawful order of a practitioner for a drug or
device for a specific patient.
(n)
"Readily retrievable" means records kept in such a manner that they can be
separated out from all other records and produced for review within forty-eight
(48) hours.
(o) "Reasonable effort"
means that degree of effort which a pharmacist of ordinary prudence and
accepted professional duty would exercise in similar circumstances.
(p) "Shared pharmacy services" means a
pharmacy or pharmacist performing functions at the request of another
pharmacy.
(q) "Supervise" means to
direct the execution of pharmacy related functions or tasks.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.